Nurse practitioners (NPs) in B.C. have a broad scope of practice, which includes drug prescribing. In 2016, NPs in B.C. were granted new authority to prescribe many controlled drugs and substances (CDS) under federal legislation. In 2017, the CRNBC Board approved practice standards for NPs to undertake continuation prescribing of buprenorphine-naloxone (suboxone) for treatment of opioid addiction.
Establishing and implementing rigorous Quality Assurance Program processes for monitoring, assessing, and acting on sub-optimal prescribing practices is integral to meeting CRNBC’s public interest mandate. The Quality Assurance Program is overseenby the QA Committee.
The QA Committee will monitor and review the prescribing of selected drugs or drug classes to identify concerns, trends or issues related to selected drugs and/or drug class prescribing practices, and provide information to
CRNBC is working closely with our partners, the College of Physicians and Surgeons of BC (CPSBC), College of Pharmacists of BC, the BC Centre on Substance Use, the Ministry of Health, as well as NPs and employers, to establish and implement prescription review policy and operational processes that reflect provincial research, experience and evaluation.
CRNBC’s Prescription Review Program will review NP prescribing practices to:
If you have any questions, please contact us: